World Conference on Obesity Pharmacotherapy and Cardiometabolic Drug Development

Important dates

1. 17 Dec

   Abstract / full paper deadline

   In 32 days

2. 18 Jan

   Conference

   Helsinki, Finland

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

In addressing the intersection of obesity and cardiometabolic health, this international conference promises to deliver evidence-based insights into pharmacotherapy advancements and drug development strategies. Researchers, clinicians, and pharmaceutical professionals are encouraged to present their original findings and experiences through various formats, including oral presentations and poster sessions. Key topics will include the role of pharmacotherapy in obesity management, understanding the effects of new drug classes, and exploring treatment paradigms for cardiometabolic diseases. A series of expert panels will foster collaborations and discussions among participants. Essential information on registration and submission guidelines will be available on the website, providing a platform for shared knowledge and innovative thinking in the realm of obesity pharmacotherapy. Attendees can expect a series of engaging sessions that will enhance their professional development and broaden their understanding of the latest trends in the field.

Call for papers

Abstracts are due by 17 December 2026. Submission details are on the official website.